1. Home
  2. ENOV vs ATRC Comparison

ENOV vs ATRC Comparison

Compare ENOV & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • ATRC
  • Stock Information
  • Founded
  • ENOV 1995
  • ATRC 2000
  • Country
  • ENOV United States
  • ATRC United States
  • Employees
  • ENOV N/A
  • ATRC N/A
  • Industry
  • ENOV Fluid Controls
  • ATRC Medical/Dental Instruments
  • Sector
  • ENOV Industrials
  • ATRC Health Care
  • Exchange
  • ENOV Nasdaq
  • ATRC Nasdaq
  • Market Cap
  • ENOV 1.6B
  • ATRC 1.6B
  • IPO Year
  • ENOV 2008
  • ATRC 2005
  • Fundamental
  • Price
  • ENOV $28.45
  • ATRC $35.31
  • Analyst Decision
  • ENOV Strong Buy
  • ATRC Strong Buy
  • Analyst Count
  • ENOV 6
  • ATRC 10
  • Target Price
  • ENOV $51.00
  • ATRC $49.60
  • AVG Volume (30 Days)
  • ENOV 1.6M
  • ATRC 712.5K
  • Earning Date
  • ENOV 08-07-2025
  • ATRC 07-29-2025
  • Dividend Yield
  • ENOV N/A
  • ATRC N/A
  • EPS Growth
  • ENOV N/A
  • ATRC N/A
  • EPS
  • ENOV N/A
  • ATRC N/A
  • Revenue
  • ENOV $2,189,576,000.00
  • ATRC $499,946,000.00
  • Revenue This Year
  • ENOV $8.23
  • ATRC $14.63
  • Revenue Next Year
  • ENOV $6.18
  • ATRC $12.62
  • P/E Ratio
  • ENOV N/A
  • ATRC N/A
  • Revenue Growth
  • ENOV 14.40
  • ATRC 16.28
  • 52 Week Low
  • ENOV $25.47
  • ATRC $20.20
  • 52 Week High
  • ENOV $49.83
  • ATRC $43.11
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 48.56
  • ATRC 58.24
  • Support Level
  • ENOV $25.72
  • ATRC $33.63
  • Resistance Level
  • ENOV $29.56
  • ATRC $37.80
  • Average True Range (ATR)
  • ENOV 1.08
  • ATRC 1.64
  • MACD
  • ENOV 0.22
  • ATRC 0.48
  • Stochastic Oscillator
  • ENOV 72.86
  • ATRC 68.47

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: